| 0.1 |
0.3 |
GO:2000502 |
negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.1 |
0.3 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.1 |
0.3 |
GO:0050894 |
determination of affect(GO:0050894) |
| 0.1 |
0.3 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) female genitalia morphogenesis(GO:0048807) |
| 0.1 |
0.2 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.1 |
1.4 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 |
0.4 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
1.1 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.2 |
GO:1902523 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.1 |
0.2 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.1 |
0.2 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.1 |
0.3 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.0 |
0.2 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 |
0.3 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.0 |
0.3 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.0 |
0.6 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.1 |
GO:1990654 |
sebum secreting cell proliferation(GO:1990654) |
| 0.0 |
0.3 |
GO:0051549 |
positive regulation of keratinocyte migration(GO:0051549) |
| 0.0 |
0.3 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.0 |
0.1 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.0 |
0.1 |
GO:0061349 |
chemoattraction of serotonergic neuron axon(GO:0036517) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
| 0.0 |
0.1 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 |
0.1 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.0 |
0.1 |
GO:0043397 |
corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.0 |
0.2 |
GO:0061767 |
negative regulation of lung blood pressure(GO:0061767) |
| 0.0 |
0.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
0.1 |
GO:0071314 |
cellular response to cocaine(GO:0071314) |
| 0.0 |
0.1 |
GO:0035711 |
T-helper 1 cell activation(GO:0035711) |
| 0.0 |
0.1 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.0 |
0.2 |
GO:0046618 |
drug export(GO:0046618) |
| 0.0 |
0.1 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.1 |
GO:0052214 |
multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.0 |
0.1 |
GO:0060129 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) regulation of calcium-independent cell-cell adhesion(GO:0051040) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.0 |
0.2 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.0 |
0.1 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.0 |
0.1 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.0 |
0.1 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.0 |
0.1 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.0 |
0.7 |
GO:0010919 |
regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.0 |
0.0 |
GO:0001545 |
primary ovarian follicle growth(GO:0001545) |
| 0.0 |
0.1 |
GO:2000625 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.0 |
0.0 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.1 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.0 |
0.1 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.0 |
0.1 |
GO:0070376 |
regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.0 |
0.1 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.0 |
0.1 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.0 |
0.0 |
GO:0061184 |
dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) positive regulation of dermatome development(GO:0061184) |
| 0.0 |
0.1 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.2 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.0 |
0.1 |
GO:1904235 |
regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.0 |
0.2 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
0.1 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.1 |
GO:0006173 |
dADP biosynthetic process(GO:0006173) |
| 0.0 |
0.0 |
GO:1903660 |
negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.0 |
0.0 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.0 |
0.0 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.0 |
0.1 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.0 |
0.0 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.0 |
0.1 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.0 |
0.1 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 |
0.1 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.0 |
0.0 |
GO:0032804 |
viral protein processing(GO:0019082) negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.0 |
0.1 |
GO:0045726 |
positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.0 |
0.0 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.0 |
0.0 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.0 |
0.0 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.0 |
0.0 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.0 |
0.3 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.1 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 0.0 |
0.0 |
GO:0002874 |
regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.0 |
0.1 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.0 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.0 |
0.2 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.2 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.0 |
0.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.1 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.0 |
0.1 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.0 |
0.1 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.0 |
0.1 |
GO:1901863 |
positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.0 |
0.1 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 0.0 |
0.1 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.0 |
0.0 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.0 |
0.2 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
0.3 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.0 |
0.1 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.0 |
0.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.0 |
0.1 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.0 |
0.1 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.0 |
0.1 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.0 |
0.1 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.0 |
0.0 |
GO:0014734 |
skeletal muscle hypertrophy(GO:0014734) |
| 0.0 |
0.0 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.0 |
0.1 |
GO:1902162 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.0 |
0.1 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.0 |
0.1 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.0 |
0.2 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.0 |
0.1 |
GO:0061591 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.0 |
0.1 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.0 |
0.0 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.0 |
0.1 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 |
0.1 |
GO:1900169 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.0 |
0.1 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.0 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.0 |
0.2 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.0 |
0.1 |
GO:0051884 |
regulation of anagen(GO:0051884) |
| 0.0 |
0.0 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.0 |
0.1 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.0 |
0.0 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.0 |
0.1 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.0 |
0.0 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.0 |
0.0 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.0 |
0.5 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.0 |
0.1 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.0 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.0 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.0 |
0.1 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
